InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
79,033.29
(
2.94%
)
Post# of 376167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sludgehound

Send PM Follow Ignore
Followers 63
Posts 13745
Boards Moderated 0
Alias Born 01/05/2003

sludgehound

Re: None

Wednesday, 04/08/2015 9:57:23 AM

Wednesday, April 08, 2015 9:57:23 AM

Post# of 376167
AEMD to do 1-50 to get Nasdaq? 0.195 now

07:14 AM EDT, 04/08/2015 (MT Newswires) -- Aethlon Medical (AEMD), which is developing targeted therapeutic devices to address infectious diseases and cancer, said it will implement a 1-for-50 reverse stock split in preparation for a possible Nasdaq listing.
The split is subject to approval by the Financial Industry Regulatory Authority (FINRA), which is expected on April 10, 2015. The reverse split will reduce the number of shares of the Company's common stock outstanding from approximately 323 million to approximately 6.7 million.
Directors approved the stock split in part to support the Nasdaq Capital Market listing application. At present, the company does not meet all of the initial listing requirements for the exchange and cannot be assured the application will be approved.
The stock closed on the OTC markets at $0.25 on Tuesday.
Price: 0.25, Change: , Percent Change:

It is hard to imagine a more stupid or more dangerous way of making decisions than by putting those decisions in the hands of people who pay no price for being wrong.

~ Thomas Sowell

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up